The Synairgen stock price reacted well - hoping mo
Post# of 148184
Synairgen SNG , a U.K. respiratory drug company, jumped 370% after announcing positive results from a trial in hospitalized COVID-19 patients. The odds of developing severe disease during the treatment period were significantly reduced by 79% for patients receiving its SNG001 compared to patients who received placebo, the company said.